DAWN RSI Chart
Last 7 days
-3.3%
Last 30 days
16.6%
Last 90 days
13.1%
Trailing 12 Months
20.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 18.1M | 0 | 0 | 0 |
2023 | 8.2M | 11.4M | 14.8M | 17.2M |
2022 | 0 | 0 | 0 | 4.7M |
2021 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 03, 2024 | bender jeremy | sold | -163,417 | 17.852 | -9,154 | chief executive officer |
May 03, 2024 | york charles n ii | sold | -144,214 | 17.8527 | -8,078 | coo, cfo and secretary |
May 02, 2024 | bender jeremy | sold | -107 | 17.9375 | -6.00 | chief executive officer |
May 02, 2024 | york charles n ii | sold | -3,579 | 17.8955 | -200 | coo, cfo and secretary |
May 01, 2024 | york charles n ii | sold | -933,397 | 17.887 | -52,183 | coo, cfo and secretary |
May 01, 2024 | bender jeremy | sold | -1,252,180 | 17.8753 | -70,051 | chief executive officer |
Apr 18, 2024 | blackman samuel c. | sold | -160,163 | 16.0163 | -10,000 | head of r&d |
Mar 25, 2024 | blackman samuel c. | sold | -160,055 | 16.0055 | -10,000 | head of r&d |
Mar 11, 2024 | blackman samuel c. | sold | -457,314 | 15.2438 | -30,000 | head of r&d |
Feb 27, 2024 | blackman samuel c. | sold | -322,166 | 16.1083 | -20,000 | head of r&d |
Which funds bought or sold DAWN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 10, 2024 | BlackRock Inc. | reduced | -1.85 | 8,278,670 | 83,119,300 | -% |
May 10, 2024 | VANGUARD GROUP INC | added | 0.1 | 9,236,170 | 78,874,500 | -% |
May 10, 2024 | DIMENSIONAL FUND ADVISORS LP | added | 26.18 | 4,856,760 | 16,215,600 | -% |
May 10, 2024 | Vontobel Holding Ltd. | sold off | -100 | -226,300 | - | -% |
May 10, 2024 | Pacer Advisors, Inc. | new | - | 14,901 | 14,901 | -% |
May 10, 2024 | GROUP ONE TRADING, L.P. | new | - | 82,683 | 82,683 | -% |
May 10, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | sold off | -100 | -891 | - | -% |
May 10, 2024 | JUPITER ASSET MANAGEMENT LTD | sold off | -100 | -535,397 | - | -% |
May 10, 2024 | CITIGROUP INC | added | 71.18 | 1,366,840 | 2,825,750 | -% |
May 10, 2024 | Covestor Ltd | reduced | -12.5 | - | - | -% |
Unveiling Day One Biopharmaceuticals, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Date Filed | Form Type | Document | |
---|---|---|---|
Peers (Alternatives to Day One Biopharmaceuticals, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 48.2B | 6.8B | -8.07 | 7.03 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 19.0B | 2.0B | -57.12 | 9.47 | ||||
BMRN | 15.3B | 2.5B | 74.39 | 6.18 | ||||
INCY | 12.9B | 3.8B | 17.35 | 3.43 | ||||
MID-CAP | ||||||||
BBIO | 5.3B | 107.9M | -9.76 | 48.09 | ||||
APLS | 5.2B | 524.1M | -12.51 | 9.96 | ||||
AXSM | 3.6B | 251.0M | -12.12 | 14.31 | ||||
ARWR | 2.7B | 240.7M | -5.82 | 12.77 | ||||
ACAD | 2.5B | 813.8M | -1.5K | 3.08 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.44 | 4.66 | ||||
NVAX | 1.8B | 996.6M | -4.62 | 1.85 | ||||
CRBP | 458.7M | 881.7K | -13.59 | 481.06 | ||||
INO | 294.6M | 4.9M | -2.36 | 60.54 | ||||
IBIO | 15.6M | 2.1M | -0.67 | 7.61 |
Day One Biopharmaceuticals, Inc. News
Income Statement (Quarterly) | |||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -13.1% | 4,365 | 5,024 | 5,291 | 3,406 | 3,466 | 2,660 | 1,895 | 189 | - | - |
Operating Expenses | 12.2% | 66,767 | 59,517 | 51,438 | 49,254 | 45,855 | 42,743 | 39,699 | 36,719 | 27,748 | 21,976 |
S&GA Expenses | -100.0% | - | 22,169 | 18,275 | 17,072 | 18,027 | 16,723 | 17,664 | 14,159 | 12,745 | 10,787 |
R&D Expenses | 7.7% | 40,210 | 37,348 | 33,163 | 32,182 | 27,828 | 26,020 | 22,035 | 22,560 | 15,003 | 11,189 |
Interest Expenses | - | - | - | - | - | - | 2,660 | 1,895 | 189 | 2.00 | 24.00 |
Net Income | -14.5% | -62,412 | -54,511 | -46,150 | -45,863 | -42,393 | -40,109 | -37,795 | -36,530 | -27,747 | -22,993 |
Net Income Margin | -5.1% | -11.55* | -10.99* | -11.77* | -14.54* | -19.10* | -29.96* | - | - | - | - |
Free Cashflow | -20.2% | -49,729 | -41,380 | -37,105 | -42,581 | -26,011 | -35,310 | -23,218 | -29,794 | -21,578 | -13,169 |
Balance Sheet | ||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2020Q4 |
Assets | -13.1% | 327 | 376 | 414 | 451 | 324 | 349 | 382 | 404 | 268 | 290 | 304 | 317 | 46.00 |
Current Assets | -13.1% | 326 | 375 | 413 | 450 | - | 348 | - | - | - | 289 | - | - | 45.00 |
Cash Equivalents | 17.2% | 270 | 231 | 241 | 189 | 49.00 | 85.00 | 121 | 389 | 263 | 284 | 297 | 310 | 44.00 |
Net PPE | -11.1% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities | 1.1% | 30.00 | 30.00 | 25.00 | 25.00 | 23.00 | 17.00 | 19.00 | 13.00 | 8.00 | 9.00 | 6.00 | 5.00 | 2.00 |
Current Liabilities | 1.1% | 30.00 | 30.00 | 24.00 | 25.00 | 23.00 | 17.00 | 18.00 | 13.00 | 8.00 | 9.00 | 6.00 | 5.00 | 2.00 |
Shareholder's Equity | -14.4% | 297 | 347 | 390 | 426 | 300 | 332 | 363 | 391 | 260 | 281 | 298 | 312 | - |
Retained Earnings | -13.6% | -521 | -458 | -404 | -357 | -312 | -269 | -229 | -191 | -155 | -127 | -105 | -86.31 | -56.84 |
Additional Paid-In Capital | 1.6% | 818 | 805 | 794 | 784 | 612 | 602 | 593 | 582 | 415 | 409 | 403 | 398 | - |
Shares Outstanding | 0.2% | 87.00 | 87.00 | 87.00 | 87.00 | 74.00 | 73.00 | 64.00 | 60.00 | 58.00 | 37.00 | 30.00 | 23.00 | - |
Float | - | - | - | - | 759 | - | - | - | 698 | - | - | - | 646 | - |
Cashflow (Quarterly) | ||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q4 |
Cashflow From Operations | -20.2% | -49,729 | -41,372 | -37,064 | -42,432 | -25,985 | -35,310 | -23,214 | -29,787 | -21,563 | -13,169 | -12,221 | -13,406 | -9,743 | -5,938 | -3,578 | - | - |
Share Based Compensation | -100.0% | - | 10,811 | 9,606 | 9,477 | 9,447 | 6,833 | 8,576 | 5,631 | 6,202 | 5,097 | 5,149 | 2,537 | 538 | 350 | 60.00 | 57.00 | - |
Cashflow From Investing | 193.9% | 89,288 | 30,380 | 88,917 | 20,274 | -11,193 | -2,210 | -246,852 | -5,997 | -15.00 | - | - | - | -8,000 | 1.00 | - | - | - |
Cashflow From Financing | -92.0% | 48.00 | 597 | 115 | 162,101 | 1,184 | 1,918 | 2,053 | 161,930 | - | 318 | -615 | 168,532 | 128,885 | - | - | - | - |
Condensed Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development | $ 40,210 | $ 27,828 |
General and administrative | 26,557 | 18,027 |
Total operating expenses | 66,767 | 45,855 |
Loss from operations | (66,767) | (45,855) |
Investment income, net | 4,365 | 3,466 |
Other expense, net | (10) | (4) |
Net loss attributable to common stockholders | $ (62,412) | $ (42,393) |
Net loss per share, basic | $ (0.72) | $ (0.59) |
Net loss per share, diluted | $ (0.72) | $ (0.59) |
Weighted-average number of common shares used in computing net loss per share, basic | 86,679,282 | 71,972,888 |
Weighted-average number of common shares used in computing net loss per share, diluted | 86,679,282 | 71,972,888 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 270,391 | $ 230,784 |
Short-term investments | 47,553 | 135,563 |
Prepaid expenses and other current assets | 8,090 | 8,927 |
Total current assets | 326,034 | 375,274 |
Property and equipment, net | 185 | 208 |
Operating lease right-of-use asset | 259 | 352 |
Deposits and other long-term assets | 167 | 214 |
Total assets | 326,645 | 376,048 |
Current Liabilities: | ||
Accounts payable | 4,780 | 2,576 |
Accrued expenses and other current liabilities | 24,759 | 26,524 |
Current portion of operating lease liabilities | 300 | 408 |
Total current liabilities | 29,839 | 29,508 |
Total liabilities | 29,839 | 29,508 |
Commitments and contingencies (Note 6) | ||
Stockholders' equity | ||
Common stock, $0.001 par value; 500,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 87,377,163 and 87,227,132 shares issued and outstanding as of Mach 31, 2024 and December 31, 2023, respectively | 9 | 9 |
Additional paid-in-capital | 817,799 | 805,107 |
Accumulated other comprehensive loss | (5) | 9 |
Accumulated deficit | (520,997) | (458,585) |
Total stockholders' equity | 296,806 | 346,540 |
Total liabilities and stockholders' equity | $ 326,645 | $ 376,048 |